Announced Mon, 29 Jun · 11:46 IST
Annual Report for Financial Year 2023-24 filed with BSE
Results View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹7.52
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.0+6.0+8.0+10.1+12.2+16.4+28.1———
Up moveDown movePending
AI summary
Kobo Biotech Ltd has submitted its Annual Report for the financial year 2023-24 to BSE. This is a routine regulatory filing that gives shareholders access to the full-year audited financial statements, directors report, and auditor observations. Detailed financials, ratios and notes are available in the attached PDF on the BSE portal.
Likely market impact
No immediate price impact expected. Investors should review full-year financials and auditor remarks for any material concerns.